Suprane Liquid
Product Images NDC 10019-641

6 FDA label images from Baxter Healthcare Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Suprane (NDC 10019-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Suprane Chemical Structure Image (Image 01)

Suprane Chemical Structure Image (Image 01)
Chemical structure of desflurane, the active ingredient in SUPRANE. The diagram depicts the molecular arrangement including fluorine (F), hydrogen (H), carbon (C), and oxygen (O) atoms connected to illustrate the compound's configuration.*
FDA Label Image

Figure 1. Paco2 During Spontaneous Ventilation In Unstimulated Volunteers (Image 02)

Figure 1. Paco2 During Spontaneous Ventilation In Unstimulated Volunteers (Image 02)
A line graph comparing the partial pressure of arterial carbon dioxide (PaCO2) in mmHg against the minimum alveolar concentration (MAC) for different volatile anesthetics including desflurane, enflurane, isoflurane, desflurane with nitrous oxide, and halothane. Error bars indicate mean ± standard error for the data points.*
FDA Label Image

Figure 2. Desflurane Washin (Image 03)

Figure 2. Desflurane Washin (Image 03)
A line graph showing the mean end-tidal anesthetic concentration (FA) relative to inspired anesthetic concentration (FI) over 30 minutes in 8 normal male volunteers. It compares Nitrous Oxide, Desflurane, Isoflurane, and Halothane, with FA/FI ratio on the vertical axis and time in minutes on the horizontal axis.*
FDA Label Image

Figure 3. Desflurane Washout (Image 04)

Figure 3. Desflurane Washout (Image 04)
A pharmacokinetic curve showing the end-tidal anesthetic concentrations (F_A) over time in minutes for three inhaled anesthetics: halothane, isoflurane, and desflurane. The y-axis is logarithmic, labeled with concentrations from 0.001 to 1. The chart displays the concentration decline for these agents in 8 normal male volunteers over approximately 150 minutes.*
FDA Label Image

Suprane Representative Container Label (Image 05)

Suprane Representative Container Label (Image 05)
Label for Suprane (desflurane, USP) liquid for inhalation, 240 mL, by Baxter Healthcare Corporation. The label includes the NDC 10019-641-60, chemical name 1,2,2,2-tetrafluoroethyl difluoromethyl ether, storage instructions at 15°-30°C, a reminder to replace the cap after each use, and contact information for product inquiry. Manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA.*
FDA Label Image

Suprane Representative Shipper/carton Label (Image 06)

Suprane Representative Shipper/carton Label (Image 06)
Label for Suprane (desflurane, USP) liquid inhalation, packaged as six 240 mL bottles. The label includes storage instructions at room temperature 15°-30°C (59°-86°F), barcode graphics, NDC number 10019-641-34, lot and expiration placeholders, and states it is manufactured for Baxter Healthcare Corporation, Deerfield, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.